Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric neoplasia.

Pelayo Correa1

  • 1Department of Pathology, Louisiana State University Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112, USA. correa@lsuhsc.ed

Current Gastroenterology Reports
|November 21, 2002
PubMed
Summary

Recent advances in gastric cancer research highlight Helicobacter pylori

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations.

Journal of clinical microbiology·2021
Same author

The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.

Gastroenterology·2020
Same author

Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection.

Cancer epidemiology·2020
Same author

Dynamics of <i>Helicobacter pylori</i> infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial.

Gut·2017
Same author

Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies.

Oncotarget·2017
Same author

Draft Genome Sequences of 13 Colombian <i>Helicobacter pylori</i> Strains Isolated from Pacific Coast and Andean Residents.

Genome announcements·2017

Area of Science:

  • Gastroenterology and Oncology
  • Pathology and Epidemiology

Background:

  • Gastric adenocarcinoma, gastrointestinal stromal tumors (GISTs), and mucosa-associated lymphoid tissue (MALT) lymphoma are significant gastrointestinal malignancies.
  • Understanding the etiology, pathogenesis, and molecular markers is crucial for diagnosis, treatment, and prevention.

Purpose of the Study:

  • To review recent significant advances in the clinical, epidemiologic, and pathologic aspects of gastric adenocarcinoma, GISTs, and MALT lymphoma.
  • To highlight the role of Helicobacter pylori in gastric carcinogenesis and MALT lymphoma development.
  • To discuss novel markers and therapeutic strategies for these gastrointestinal tumors.

Main Methods:

  • Comprehensive literature review of recent studies on gastric adenocarcinoma, GISTs, and MALT lymphoma.
  • Analysis of advances in understanding disease etiology, pathogenesis, and molecular pathology.
  • Evaluation of new diagnostic markers and therapeutic approaches.

Main Results:

  • Advances in distal gastric adenocarcinoma focus on etiology and pathogenesis, particularly the inflammatory response to Helicobacter pylori.
  • New markers for GISTs aid in identifying the cell of origin and developing targeted therapies for metastatic disease.
  • MALT lymphomas are linked to H. pylori; molecular markers help differentiate treatment responses to eradication versus chemotherapy.

Conclusions:

  • Understanding H. pylori's role in gastric carcinogenesis informs prevention strategies for high-risk populations.
  • Novel GIST markers enable effective drug development and monitoring, even in advanced stages.
  • Targeted therapies based on molecular markers are crucial for managing H. pylori-associated MALT lymphomas.

Related Experiment Videos